No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
Established in 2016 and headquartered in Sydney, Australia, InhaleRx Limited is an Australian company primarily engaged in advancing and bringing to market medical drug delivery systems. The firm also dedicates efforts to developing specialized inhaled drug formulations. A notable product within its portfolio is the Medihale inhaler, a distinctive sealed-pod device engineered for compatibility with its inhaled medications. This entity formerly traded as Lifespot Health Ltd, officially adopting the name InhaleRx Limited in October 2021.
inhalerx.com.auNo one on the platform currently holds IRX.AX.
No tracked institution reports a position in IRX.AX as of their last filing.
No one on the platform has traded IRX.AX yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| IRX.AXInhaleRx Limited | $0.03 | +0.00% | $7M | — |
| ACR.AXAcrux Limited | $0.01 | +0.00% | $6M | — |
| ADR.AXAdherium Limited | $0.09 | +0.00% | $2M | — |
| BGT.AXBio-Gene Technology Limited | $0.02 | +0.00% | $5M | — |
| BIT.AXBiotron Limited | $0.00 | +0.00% | $3M | — |
| CAN.AXCann Group Limited | $0.01 | +0.00% | $4M | — |
| GLH.AXGlobal Health Limited | $0.05 | +0.00% | $3M | — |
Source: Financial Modeling Prep · peers by sector/industry